NCT06047015 2024-08-09
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
University of Saskatchewan
Phase 1/2 Not yet recruiting
Clinical Trials
11 trialsNCT01939665 2022-12-20
PANFIRE
Amsterdam UMC, location VUmc
Phase 1/2 Completed
NCT04816045 2021-03-25
Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial
Zealand University Hospital
Phase 1/2 Unknown
NCT03180437 2020-11-02
Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03183219 2020-07-13
Safety and Efficiency of γδ T Cell Against Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03183232 2020-07-13
Safety and Efficiency of γδ T Cell Against Lung Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02718859 2019-09-12
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03008343 2019-09-12
Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02822066 2016-07-04
Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas
First Affiliated Hospital of Zhejiang University
Phase 1/2 Unknown
NCT01764009 2015-09-11
AIMM
Valerio Therapeutics
Phase 1/2 Withdrawn
NCT01967407 2014-11-19
IRENE
University of Magdeburg
Phase 1/2 Unknown